Stock Upgrades Today: Traders Watch $CRSP $CVS $HSIC and More

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  14 Aug 2025
 

•   CRSP  
   
  +1.13%
•   CVS  
   
  +0.15%
•   HSIC  
   
  -0.07%
•   LCID  
   
  -0.44%
•   NTES  
   
  +0.11%

$CRSP Crispr Therapeutics earned an upgrade to Hold ahead of what analysts expect to be a catalyst-rich second half of 2025. The stock climbed 2.71% on elevated volume, reflecting investor optimism that upcoming data readouts and pipeline updates could provide fresh momentum for this gene-editing leader.

$CVS CVS Health received a nod from Wall Street’s top analysts, securing an upgrade that pushed the stock up 1.2%. The healthcare giant’s consistent earnings and operational efficiency continue to appeal to institutional investors, signaling steady confidence in its long-term strategy.

$HSIC Henry Schein’s upgrade from Hold to Buy highlights renewed confidence in the company’s growth trajectory. While shares were slightly lower on the day, analysts point to its expanding dental and medical solutions business as a key driver for potential upside, making HSIC a compelling stock for investors seeking steady gains.

$LCID Lucid stock, despite a small pullback today, is benefiting from a recent 16.6% surge in July tied to a major robotaxi deal and upgraded vehicle lineup. Analysts see its strategic investments in mobility and autonomous tech as catalysts that could fuel further upside, positioning LCID as a long-term growth play.

$NTES NetEase maintained a Buy rating with strong second-quarter results and accelerated deferred revenue growth. Analysts highlight the company’s ability to monetize digital content and games, suggesting that NTES is well-positioned for continued revenue expansion even amid market volatility.

$POWL Powell Industries’ strong recent results reinforced a Buy rating. Investors responded favorably to operational execution and backlog growth, which indicate that the company’s industrial solutions segment remains resilient, offering a mix of stability and upside potential.

$RIVN Rivian retained its Buy rating with a target price of $18. The stock reflects optimism around production scaling and delivery improvements, making it a stock to watch as the EV market continues to evolve.

$RKLB Rocket Lab received an upgrade following the finalization of its Geost takeover. The stock’s modest decline today masks strong long-term potential in the aerospace and satellite launch sector, with analyst upgrades suggesting growing confidence in RKLB’s strategic positioning.

$SDGR Schrodinger saw a positive rating initiation with an Overweight call and price target of $25. Analysts point to its computational chemistry platform as a key differentiator in drug discovery, signaling strong growth prospects for this biotech software innovator.

$SHW Sherwin-Williams shed its bearish label, with analysts upgrading it from Underweight to Equal-Weight and raising its price target. The paint and coatings leader’s strong fundamentals and resilient consumer demand underlie renewed market confidence.

$UEC Uranium Energy benefited from a Buy rating reaffirmation and a higher price target, reflecting increasing interest in nuclear energy as a long-term growth sector. Analysts and influencers like Jim Cramer highlight uranium’s strategic positioning for future energy demand.

$VIPS Vipshop Holdings earned a Relative Strength rating upgrade, emphasizing its improving technical performance and market momentum. Shares rose 5.9% on notable volume, signaling both short-term strength and potential for continued gains as e-commerce dynamics evolve.

View All Headlines